Pharmaceutical Executive-08-01-2020

Pharmaceutical Executive, August 2020 Issue (PDF)

August 12, 2020

Issue PDF

40

8

Click here for a link to open the Pharmaceutical Executive August 2020 issue in an interactive PDF format.

Pharm Exec’s 19th Annual Industry Audit

August 11, 2020

Features

40

8

Our latest review of biopharma financial performance reveals solid growth rates in enterprise value and rebounding value-to-sales numbers—proving once again the business imperative of regaining and sustaining shareholder value.

Pricing, Innovation, and a Pound of Flesh

August 10, 2020

From the Editor

40

8

How “Contractual Genericization” could revitalize pharma and reframe the public conversation.

Strategic Realignment for a Better Future

August 10, 2020

Features

40

8

In adjusting to the long-term aftershocks from the coronavirus pandemic, pharma companies will need to focus on change in three core areas.

Tackling a ‘Genius Virus’

August 10, 2020

Features

40

8

Patrick Soon-Shiong, the billionaire biotech entrepreneur and owner of NantWorks, a network of health startups, discusses his companies’ COVID-19 vaccine candidate and its “fighting chance” to outsmart the virus’s hidden tricks through merging supercomputing and modernized DNA delivery.

The New Data Dynamic: How COVID-19 has Upended Model

August 10, 2020

Features

40

8

While exposing gaps in the way pharma acquires and uses data, the pandemic has also fostered a new spirit of information sharing that bodes well for future collaborations.

Holograms as Industry Tool Here to Stay

August 07, 2020

Columns

40

8

Their application for security and anti-counterfeiting purposes continues to evolve, especially in combination with digital technology.